CISPLATIN-BASED CHEMOTHERAPY IN DYSGERMINOMA OF THE OVARY - 13-YEAR EXPERIENCE AT THE INSTITUT-GUSTAVE-ROUSSY

被引：19

作者：

CULINE, S

LHOMME, C

KATTAN, J

DUVILLARD, P

MICHEL, G

GERBAULET, A

DROZ, JP

机构：

[1] INST GUSTAVE ROUSSY,DEPT MED,F-94805 VILLEJUIF,FRANCE

[2] INST GUSTAVE ROUSSY,DEPT PATHOL,F-94805 VILLEJUIF,FRANCE

[3] INST GUSTAVE ROUSSY,DEPT SURG,F-94805 VILLEJUIF,FRANCE

[4] INST GUSTAVE ROUSSY,DEPT RADIOTHERAPY,F-94805 VILLEJUIF,FRANCE

[5] CTR LEON BERARD,DEPT MED ONCOL,F-69008 LYON,FRANCE

来源：

GYNECOLOGIC ONCOLOGY | 1995年 / 58卷 / 03期

关键词：

D O I：

10.1006/gyno.1995.1240

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Twelve patients with dysgerminoma of the ovary were treated with various cisplatin-based chemotherapy regimens. Chemotherapy was delivered as primary postoperative treatment in 6 patients. All of them are free of disease 18 to 180 months after initiation of chemotherapy. Six other patients received chemotherapy as part of the salvage treatment for recurrent disease. Three failures were observed: one toxic death, one primary failure, and one subsequent relapse. Three patients remain free of disease 50 to 95 months after initiation of chemotherapy. The role of chemotherapy in early- and advanced-stage dysgerminoma of the ovary is reviewed. (C) 1995 Academic Press, Inc.

引用

页码：344 / 348

页数：5

共 23 条

[1] RANDOMIZED TRIAL OF ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH GOOD-RISK GERM-CELL TUMORS - A MULTIINSTITUTIONAL STUDY [J].

BAJORIN, DF ;

SAROSDY, MF ;

PFISTER, DG ;

MAZUMDAR, M ;

MOTZER, RJ ;

SCHER, HI ;

GELLER, NL ;

FAIR, WR ;

HERR, H ;

SOGANI, P ;

SHEINFELD, J ;

RUSSO, P ;

VLAMIS, V ;

CAREY, R ;

VOGELZANG, NJ ;

CRAWFORD, ED ;

BOSL, GJ .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :598-606

[2]

BJORKHOLM E, 1990, CANCER-AM CANCER SOC, V65, P38, DOI 10.1002/1097-0142(19900101)65:1<38::AID-CNCR2820650110>3.0.CO

[3]

2-U

[4] GERM-CELL TUMORS OF THE OVARY - THE EXPERIENCE OF THE NATIONAL-CANCER-INSTITUTE OF MILAN .1. DYSGERMINOMA [J].

DEPALO, G ;

LATTUADA, A ;

KENDA, R ;

MUSUMECI, R ;

ZANINI, M ;

PILOTTI, S ;

BELLANI, FF ;

DIRE, F ;

BANFI, A .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (06) :853-860

[5]

GERBAULET A, 1988, B CANCER, V75, P598

[6] TREATMENT OF MALIGNANT GERM-CELL TUMORS OF THE OVARY WITH BLEOMYCIN, ETOPOSIDE, AND CISPLATIN [J].

GERSHENSON, DM ;

MORRIS, M ;

CANGIR, A ;

KAVANAGH, JJ ;

STRINGER, CA ;

EDWARDS, CL ;

SILVA, EG ;

WHARTON, JT .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) :715-720

[7] MENSTRUAL AND REPRODUCTIVE FUNCTION AFTER TREATMENT WITH COMBINATION CHEMOTHERAPY FOR MALIGNANT OVARIAN GERM-CELL TUMORS [J].

GERSHENSON, DM .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (02) :270-275

[8]

GERSHENSON DM, 1986, CANCER-AM CANCER SOC, V58, P2594, DOI 10.1002/1097-0142(19861215)58:12<2594::AID-CNCR2820581207>3.0.CO

[9]

2-Z

[10] UPDATE ON MALIGNANT OVARIAN GERM-CELL TUMORS [J].

GERSHENSON, DM .

CANCER, 1993, 71 (04) :1581-1590

← 1 2 3 →